Transforaminal endoscopic discectomy versus microdiscectomy for lumbar disc herniation .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
A randomised controlled trial of transforaminal endoscopic discectomy vs microdiscectomy
Eur Spine J. 2017 Mar;26(3):847-856140 patients with single-level lumbar disc herniation were randomized to either transforaminal endoscopic discectomy or microdiscectomy. Patients were evaluated over a 2-year follow-up for back pain on a visual analog scale (VAS), leg pain on a VAS, disability on the Oswestry Disability Index (ODI), and health-related quality-of-life on the Short Form 36. The results of this trial indicated that disability and back pain were similar between the two groups over the 2-year follow-up, while leg pain severity at 2 years was significantly lower among those who were treated with transforaminal endoscopic discectomy. Radiation exposure during surgery was significantly higher, while length of hospital stay was significantly shorter, in patients treated with transforaminal endoscopic discectomy.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics